정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1808 | Active, not recruiting | COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 | COVID-19 | Drug: Apixaban 2.5 MG Drug: Apixaban 5MG Drug: Aspirin Drug: Placebo |
Phase 3 | Frank C Sciurba, National Heart, Lung, and Blood Institute (NHLBI) | OTHER | 657 | All | 40 Years ~ 80 Years | University of Southern California, Los Angeles, California, United States Stanford University School of Medicine, Palo Alto, California, United States Zuckerberg San Francisco General, San Francisco, California, United States Olive View-UCLA Medical Center, Sylmar, California, United States Pine Ridge Family Medicine, Colorado Springs, Colorado, United States Life Tree Health, Inc., Washington, District of Columbia, United States Midland Florida Clinical Research Center, LLC, DeLand, Florida, United States University of Florida at Gainesville, Gainesville, Florida, United States Vital Pharma Research, Hialeah, Florida, United States Advanced Research for Health Improvement, LLC, Immokalee, Florida, United States University of Floridia at Jacksonville, Jacksonville, Florida, United States Lakeland Regional, Lakeland, Florida, United States Total Research Group LLC, Miami, Florida, United States Jackson Memorial, Miami, Florida, United States Well Pharma Medical Research, Miami, Florida, United States Innovation Clinical Trials, Palmetto Bay, Florida, United States Bond Community Health Center, Tallahassee, Florida, United States Tallahassee Memorial, Tallahassee, Florida, United States USF Tampa General Hospital, Tampa, Florida, United States Alliance Clinical Research, Tampa, Florida, United States Hawaii Pacific Health, Honolulu, Hawaii, United States Fox Valley Clinical Research Center, LLC, Aurora, Illinois, United States UIC - Mile Square, Chicago, Illinois, United States Jesse Brown VA, Chicago, Illinois, United States University of Illinois at Chicago, Chicago, Illinois, United States Olivo Wellness Medical Center, Chicago, Illinois, United States University of Chicago, Chicago, Illinois, United States OSF Saint Francis Medical Center, Peoria, Illinois, United States Ascension Via Christi, Wichita, Kansas, United States University Medical Center New Orleans, New Orleans, Louisiana, United States Jadestone Clinical Research, LLC, Gaithersburg, Maryland, United States Brigham & Women's Hospital, Boston, Massachusetts, United States GFC of Southeastern Michigan, Detroit, Michigan, United States SRI International, Plymouth, Michigan, United States Metro Health-University of Michigan Health, Wyoming, Michigan, United States Raritan Bay Primary Care and Cardiology Associates, Matawan, New Jersey, United States G&S Medical Associates, LLC, Paterson, New Jersey, United States University of New Mexico, Albuquerque, New Mexico, United States Montefiore Medical Center, Bronx, New York, United States Strong Memorial, Rochester, New York, United States Spinal Pain and Rehab Medicine, Yonkers, New York, United States Duke, Durham, North Carolina, United States Peters Medical Research, High Point, North Carolina, United States The Heart and Medical Center, Durant, Oklahoma, United States Ascension St. John Clinical Research Institute, Tulsa, Oklahoma, United States UPMC Passavant Cranberry, Cranberry, Pennsylvania, United States UPMC McKeesport, McKeesport, Pennsylvania, United States UPMC East, Monroeville, Pennsylvania, United States UPMC Magee, Pittsburgh, Pennsylvania, United States UPMC Presby, Pittsburgh, Pennsylvania, United States UPMC Mercy, Pittsburgh, Pennsylvania, United States Preferred Primary Care Physicians, Pittsburgh, Pennsylvania, United States UPMC Shadyside, Pittsburgh, Pennsylvania, United States UPMC Passavant McCandless, Pittsburgh, Pennsylvania, United States Preferred Primary Care Physicians, Inc, Pittsburgh, Pennsylvania, United States Preferred Primary Care Physicians, Pittsburgh, Pennsylvania, United States Preferred Primary Care Physicians, Uniontown, Pennsylvania, United States Pharma Tex Research, Amarillo, Texas, United States Ascension Seton Medical Center, Austin, Texas, United States Baptist Beaumont, Beaumont, Texas, United States McGoven Medical School - UT- Houston, Houston, Texas, United States Diversifield Medical Practices, Houston, Texas, United States Next Level Urgent Care, Houston, Texas, United States Mesquite Regional Internal Medicine, Mesquite, Texas, United States University of Texas at Tyler, Tyler, Texas, United States University of Texas at Rio Grande Valley, Weslaco, Texas, United States Intermountain Healthcare, Murray, Utah, United States Community Care of Clay, Clay, West Virginia, United States University Healthcare Physicians, Harpers Ferry, West Virginia, United States Community Care of Weston, Weston, West Virginia, United States Gundersen Health System, La Crosse, Wisconsin, United States |
| 1807 | Completed | COVID-19 PrEP HCW HCQ Study | COVID-19 | Drug: Hydroxychloroquine (HCQ) | Phase 2 | NYU Langone Health | OTHER | 130 | All | 18 Years | NYU Langone Health, New York, New York, United States |
| 1806 | Recruiting | COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; | Respiratory Viral Infection | Drug: Interferon alfa Drug: Selinexor Drug: Lenzilumab |
Phase 3 | Peter MacCallum Cancer Centre, Australia | OTHER | 2282 | All | 18 Years | Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia |
| 1805 | Terminated | COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study | Corona Virus Infection | Drug: Dexamethasone | Phase 4 | General Practitioners Research Institute, Huisartsenzorg Drenthe | NETWORK | 17 | All | 18 Years | GPRI, Groningen, Netherlands |
| 1804 | Recruiting | COVID-19 Prophylaxis South Africa (COVER HCW) | SARS-CoV Infection | Drug: Nitazoxanide Drug: Sofosbuvir/Daclatasvir |
Phase 2 | University of Witwatersrand, South Africa | OTHER | 1950 | All | 18 Years ~ 99 Years | Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, Gauteng, South Africa Sunnyside Office Park, Johannesburg, Gauteng, South Africa |
| 1803 | Active, not recruiting | COVID-19 Protection After Transplant Pilot Study | Kidney Transplant Recipients | Biological: mRNA-1273 vaccine (Pfizer/BioNTech) Biological: mRNA-1273 vaccine (Moderna) |
Phase 2 | National Institute of Allergy and Infectious Diseases (NIAID), PPD | NIH | 81 | All | 18 Years | Johns Hopkins Hospital, Baltimore, Maryland, United States |
| 1802 | Recruiting | COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir | Post-exposure Prophylaxis | Drug: Lopinavir/ritonavir | Phase 3 | Darrell Tan | OTHER | 1220 | All | 18 Months | St. Paul's Hospital, Vancouver, British Columbia, Canada Sunnybrook Hospital, Toronto, Ontario, Canada St. Michael's Hospital, Toronto, Ontario, Canada Toronto General Hospital, Toronto, Ontario, Canada |
